Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Somatostatin receptor 2A in gliomas: Association with oligodendrogliomas and favourable outcome.

Oncotarget - 25 Jul 2017

Kiviniemi Aida, Gardberg Maria, Kivinen Katri, Posti Jussi P, Vuorinen Ville, Sipilä Jussi, Rahi Melissa, Sankinen Matti, Minn Heikki

Abstract excerpt

Somatostatin receptor subtype 2A (SSTR2A) is a potential therapeutic target in gliomas. Data on SSTR2A expression in different glioma entities, however, is particularly conflicting. Our objective was to characterize SSTR2A status and explore its impact on survival in gliomas classified according to the specific molecular signatures of the updated WHO classification. In total, 184 glioma samples were...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Chromosome Aberrations
Share to Combined Modality Therapy

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Glioma

Share to Neoplasm Grading

Share to Oligodendroglioma

Share to Proportional Hazards Models

Share to Receptors, Somatostatin

Share to Survival Analysis

Source

Open in PubMed Open full text

Identifiers

PMID: 28467778
DOI: 10.18632/oncotarget.17097
PMCID: PMC5564754

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 5 Sept 2026. Manifest publication-graph-cohort-2026-09-05.1.

Source receipt: pubmed, retrieved 5 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 11 closest

Somatostatin receptor 2A in gliomas: Association with oligodendrogliomas and favourable outcome.PMID 28467778Read ↗

Somatostatin receptor 2A protein expression characterizes anaplastic oligodendrogliomas with favorable outcome.Semantic proximity Read ↗

Molecular analysis of the somatostatin receptor subtype 2 in human glioma cells.Semantic proximity Read ↗

Somatostatin Receptor 2 Overexpression in Hepatocellular Carcinoma: Implications for Cancer Biology and Theranostic ApplicationsSemantic proximity Read ↗

The Potential Complementary Role of Imaging with 68Ga[68Ga-RGD] PET and MRI in Recurrent Adult GliomaSemantic proximity Read ↗

Neuroendocrine tumors in the brain.Semantic proximity Read ↗

Characterization of Somatostatin Receptor 2 Gene Expression and Immune Landscape in Sinonasal MalignanciesSemantic proximity Read ↗

A pan-cancer analysis of the clinical and genetic portraits of somatostatin receptor expressing-tumor as a potential target of peptide receptor imaging and therapySemantic proximity Read ↗

Up-regulation of EphA2 and down-regulation of EphrinA1 are associated with the aggressive phenotype and poor prognosis of malignant glioma.Semantic proximity Read ↗

High ATP2A2 expression correlates with better prognosis of diffuse astrocytic tumor patients.Semantic proximity Read ↗

Glutamine synthetase expression as a valuable marker of epilepsy and longer survival in newly diagnosed glioblastoma multiformeSemantic proximity Read ↗

PDGFRA gain in low-grade diffuse gliomas.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.